Logo image of AEYE

AUDIOEYE INC (AEYE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AEYE - US0507342014 - Common Stock

9.33 USD
+0.44 (+4.95%)
Last: 1/22/2026, 10:39:44 AM
Fundamental Rating

2

AEYE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 277 industry peers in the Software industry. AEYE has a bad profitability rating. Also its financial health evaluation is rather negative. AEYE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • AEYE had negative earnings in the past year.
  • AEYE had a positive operating cash flow in the past year.
  • AEYE had negative earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: AEYE reported negative operating cash flow in multiple years.
AEYE Yearly Net Income VS EBIT VS OCF VS FCFAEYE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

  • AEYE has a worse Return On Assets (-11.53%) than 65.34% of its industry peers.
  • Looking at the Return On Equity, with a value of -62.17%, AEYE is doing worse than 72.56% of the companies in the same industry.
Industry RankSector Rank
ROA -11.53%
ROE -62.17%
ROIC N/A
ROA(3y)-26.67%
ROA(5y)-33.65%
ROE(3y)-77.04%
ROE(5y)-81.35%
ROIC(3y)N/A
ROIC(5y)N/A
AEYE Yearly ROA, ROE, ROICAEYE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K

1.3 Margins

  • AEYE has a better Gross Margin (78.61%) than 76.53% of its industry peers.
  • In the last couple of years the Gross Margin of AEYE has grown nicely.
  • AEYE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.9%
GM growth 5Y6.09%
AEYE Yearly Profit, Operating, Gross MarginsAEYE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1

2. Health

2.1 Basic Checks

  • AEYE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, AEYE has more shares outstanding
  • The number of shares outstanding for AEYE has been increased compared to 5 years ago.
  • AEYE has a better debt/assets ratio than last year.
AEYE Yearly Shares OutstandingAEYE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
AEYE Yearly Total Debt VS Total AssetsAEYE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • AEYE has an Altman-Z score of -0.92. This is a bad value and indicates that AEYE is not financially healthy and even has some risk of bankruptcy.
  • AEYE has a worse Altman-Z score (-0.92) than 76.53% of its industry peers.
  • AEYE has a debt to FCF ratio of 15.63. This is a negative value and a sign of low solvency as AEYE would need 15.63 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 15.63, AEYE is in line with its industry, outperforming 49.46% of the companies in the same industry.
  • A Debt/Equity ratio of 2.23 is on the high side and indicates that AEYE has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 2.23, AEYE is doing worse than 83.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.23
Debt/FCF 15.63
Altman-Z -0.92
ROIC/WACCN/A
WACC11.52%
AEYE Yearly LT Debt VS Equity VS FCFAEYE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

  • AEYE has a Current Ratio of 1.00. This is a bad value and indicates that AEYE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AEYE has a worse Current ratio (1.00) than 74.73% of its industry peers.
  • AEYE has a Quick Ratio of 1.00. This is a bad value and indicates that AEYE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AEYE's Quick ratio of 1.00 is on the low side compared to the rest of the industry. AEYE is outperformed by 73.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
AEYE Yearly Current Assets VS Current LiabilitesAEYE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

6

3. Growth

3.1 Past

  • AEYE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.63%.
  • AEYE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.57%.
  • Measured over the past years, AEYE shows a very strong growth in Revenue. The Revenue has been growing by 26.73% on average per year.
EPS 1Y (TTM)-29.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)18.57%
Revenue growth 3Y12.84%
Revenue growth 5Y26.73%
Sales Q2Q%14.59%

3.2 Future

  • The Earnings Per Share is expected to grow by 44.54% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 13.04% on average over the next years. This is quite good.
EPS Next Y43.46%
EPS Next 2Y45.88%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue Next Year14.49%
Revenue Next 2Y12.88%
Revenue Next 3Y13.04%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AEYE Yearly Revenue VS EstimatesAEYE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
AEYE Yearly EPS VS EstimatesAEYE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AEYE. In the last year negative earnings were reported.
  • AEYE is valuated quite expensively with a Price/Forward Earnings ratio of 207.89.
  • Based on the Price/Forward Earnings ratio, AEYE is valued a bit more expensive than the industry average as 62.45% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of AEYE to the average of the S&P500 Index (24.30), we can say AEYE is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 207.89
AEYE Price Earnings VS Forward Price EarningsAEYE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as AEYE.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as AEYE.
Industry RankSector Rank
P/FCF 139.78
EV/EBITDA 84.21
AEYE Per share dataAEYE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AEYE does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as AEYE's earnings are expected to grow with 44.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.88%
EPS Next 3Y44.54%

0

5. Dividend

5.1 Amount

  • AEYE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AUDIOEYE INC

NASDAQ:AEYE (1/22/2026, 10:39:44 AM)

9.33

+0.44 (+4.95%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-13
Earnings (Next)04-27
Inst Owners37.81%
Inst Owner Change-0.03%
Ins Owners32.73%
Ins Owner Change-1.79%
Market Cap115.88M
Revenue(TTM)39.54M
Net Income(TTM)-3.51M
Analysts81.82
Price Target21.93 (135.05%)
Short Float %7.36%
Short Ratio5.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-90.92%
Min EPS beat(2)-183.8%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-666.37%
Min EPS beat(4)-1276.47%
Max EPS beat(4)1.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.42%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-2.25%
Revenue beat(4)0
Avg Revenue beat(4)-2.14%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)-1.75%
Revenue beat(8)0
Avg Revenue beat(8)-1.96%
Revenue beat(12)0
Avg Revenue beat(12)-1.98%
Revenue beat(16)0
Avg Revenue beat(16)-1.78%
PT rev (1m)-3.15%
PT rev (3m)-3.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 207.89
P/S 2.93
P/FCF 139.78
P/OCF 41.61
P/B 20.51
P/tB N/A
EV/EBITDA 84.21
EPS(TTM)-0.35
EYN/A
EPS(NY)0.04
Fwd EY0.48%
FCF(TTM)0.07
FCFY0.72%
OCF(TTM)0.22
OCFY2.4%
SpS3.18
BVpS0.45
TBVpS-1.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.53%
ROE -62.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.61%
FCFM 2.1%
ROA(3y)-26.67%
ROA(5y)-33.65%
ROE(3y)-77.04%
ROE(5y)-81.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.9%
GM growth 5Y6.09%
F-Score5
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 2.23
Debt/FCF 15.63
Debt/EBITDA 8.95
Cap/Depr 54.76%
Cap/Sales 4.95%
Interest Coverage N/A
Cash Conversion 197.38%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z -0.92
F-Score5
WACC11.52%
ROIC/WACCN/A
Cap/Depr(3y)77.02%
Cap/Depr(5y)97.08%
Cap/Sales(3y)5.53%
Cap/Sales(5y)5.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y43.46%
EPS Next 2Y45.88%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue 1Y (TTM)18.57%
Revenue growth 3Y12.84%
Revenue growth 5Y26.73%
Sales Q2Q%14.59%
Revenue Next Year14.49%
Revenue Next 2Y12.88%
Revenue Next 3Y13.04%
Revenue Next 5YN/A
EBIT growth 1Y-2.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year625.69%
EBIT Next 3Y119.82%
EBIT Next 5YN/A
FCF growth 1Y127.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y370.39%
OCF growth 3YN/A
OCF growth 5YN/A

AUDIOEYE INC / AEYE FAQ

What is the fundamental rating for AEYE stock?

ChartMill assigns a fundamental rating of 2 / 10 to AEYE.


What is the valuation status for AEYE stock?

ChartMill assigns a valuation rating of 2 / 10 to AUDIOEYE INC (AEYE). This can be considered as Overvalued.


Can you provide the profitability details for AUDIOEYE INC?

AUDIOEYE INC (AEYE) has a profitability rating of 2 / 10.


What is the expected EPS growth for AUDIOEYE INC (AEYE) stock?

The Earnings per Share (EPS) of AUDIOEYE INC (AEYE) is expected to grow by 43.46% in the next year.